These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17380565)

  • 1. Fatal attraction?
    Harv Heart Lett; 2007 Mar; 17(7):6. PubMed ID: 17380565
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnet decoration, beautiful but potentially dangerous for patients with implantable pacemakers or defibrillators.
    Li H
    Heart Rhythm; 2007 Jan; 4(1):5-6. PubMed ID: 17198981
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential interference of small neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators.
    Wolber T; Ryf S; Binggeli C; Holzmeister J; Brunckhorst C; Luechinger R; Duru F
    Heart Rhythm; 2007 Jan; 4(1):1-4. PubMed ID: 17198980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators: an in vitro study.
    Ryf S; Wolber T; Duru F; Luechinger R
    Technol Health Care; 2008; 16(1):13-8. PubMed ID: 18334784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers.
    Roguin A
    J Am Coll Cardiol; 2009 Aug; 54(6):556-7. PubMed ID: 19643319
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 8. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of infected pacemakers and implantable cardioverter-defibrillators.
    Sohail MR
    Intern Med J; 2007 Jul; 37(7):509-10; author reply 510. PubMed ID: 17547736
    [No Abstract]   [Full Text] [Related]  

  • 10. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pacemaker and automated implantable defibrillator in daily care].
    Lotton P
    Soins; 2008; (722 Suppl):S3-4. PubMed ID: 18340988
    [No Abstract]   [Full Text] [Related]  

  • 12. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infections associated with permanent pacemakers and implantable cardioverters-defibrillators].
    Mazurek M; Grzegorzewski B; Kargul W
    Kardiol Pol; 2009 Mar; 67(3):305-9. PubMed ID: 19378239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Emergencies in patients with implanted pacemakers or defibrillators].
    Buob A; Neuberger HR; Böhm M; Mewis C
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1253-8. PubMed ID: 18509803
    [No Abstract]   [Full Text] [Related]  

  • 15. [Remote monitoring of automatic implantable cardiovascular devices (pacemakers, implantable cardioverter defibrillator and cardiac resynchronization)].
    Guevara-Valdivia ME
    Arch Cardiol Mex; 2009; 79(3):221-5. PubMed ID: 19902671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pacemaker inhibition: a manifestation of an unusual form of device-device interaction.
    Issa ZF
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1112-3. PubMed ID: 17532780
    [No Abstract]   [Full Text] [Related]  

  • 17. Get the lead out. Removing broken or infected pacemaker leads is a delicate art.
    Harv Heart Lett; 2008 Sep; 19(1):4-5. PubMed ID: 18946916
    [No Abstract]   [Full Text] [Related]  

  • 18. The risks of diathermy in the urological patient with a pacemaker or an automatic internal cardiac defibrillator.
    Meyer JP; Crew J
    BJU Int; 2008 Mar; 101(5):528-9. PubMed ID: 18257854
    [No Abstract]   [Full Text] [Related]  

  • 19. The recall genie: time to go back in the bottle.
    Newman D; Crystal E; Goldman B
    Pacing Clin Electrophysiol; 2004 Apr; 27(4):435-6. PubMed ID: 15078393
    [No Abstract]   [Full Text] [Related]  

  • 20. Yes we can! But should we? Lead extraction for superfluous pacemaker and implanted cardioverter-defibrillator leads.
    Bracke FA
    Europace; 2009 May; 11(5):546-7. PubMed ID: 19359335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.